Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NFE2L2 | Q16236 | 7/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.38 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | PKM | P14618 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | GRIN2D | O15399 | 2/20 | 0.33 |
| ▸ | GRIN3B | O60391 | 2/20 | 0.33 |
| ▸ | GRIN1 | Q05586 | 2/20 | 0.33 |
| ▸ | GRIN2A | Q12879 | 2/20 | 0.33 |
| ▸ | GRIN2B | Q13224 | 2/20 | 0.33 |
| ▸ | GRIN2C | Q14957 | 2/20 | 0.33 |
| ▸ | GRIN3A | Q8TCU5 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3662224 | 1.00 | NFE2L2 (0.38) | NFE2L2CYP1A2TRPA1CYP3A4CYP2C9 | |
| SCHEMBL3661458 | 0.88 | TRPA1 (0.39) | TRPA1NPC1MEN1PKMKMT2A | |
| SCHEMBL3776016 | 0.88 | TRPA1 (0.39) | TRPA1NPC1MEN1PKMKMT2A | |
| SCHEMBL3773771 | 0.86 | ALDH1A1 (0.33) | CYP1A2TRPA1CYP3A4CYP2C9CYP2C19 | |
| SCHEMBL3773765 | 0.86 | ALDH1A1 (0.33) | CYP1A2TRPA1CYP3A4CYP2C9CYP2C19 | |
| SCHEMBL3766720 | 0.86 | CES2 (0.38) | NFE2L2CYP1A2TRPA1CYP3A4CYP2C9 | |
| SCHEMBL3661741 | 0.86 | CES2 (0.38) | NFE2L2CYP1A2TRPA1CYP3A4CYP2C9 | |
| SCHEMBL2799258 | 0.75 | MEN1 (0.37) | CYP1A2TRPA1CYP2C9CYP2C19MEN1 | |
| SCHEMBL2799262 | 0.75 | MEN1 (0.37) | CYP1A2TRPA1CYP2C9CYP2C19MEN1 | |
| SCHEMBL3782287 | 0.75 | NFE2L2 (0.47) | NFE2L2TRPA1L3MBTL1CES2CES1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100317515-A1 | Azolylmethyloxiranes, use Thereof and Agents Containing the Same | BASF SE (DE) | 2010-12-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100317515-A1 | Azolylmethyloxiranes, use Thereof and Agents Containing the Same | XDH, NOX5, TET1 | NFE2L2 825/4885CYP1A2 28/4885TRPA1 2075/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.